Your session is about to expire
← Back to Search
Tobacco Marketplace Study for Cigarette Smoking
Study Summary
This trial uses an Experimental Tobacco Marketplace to study the purchase of tobacco products in menthol cigarette smokers. A greater understanding of tobacco product purchasing could help inform possible regulatory actions by the Food and Drug Administration.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am unable to give consent for myself.I have a history of eye conditions or use visual aids like screen readers.I am under the age of 18.You are pregnant.I smoke menthol cigarettes that have a non-menthol version.You live in Western New York.
- Group 1: Prevention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there available slots for individuals who wish to participate in this investigation?
"According to official records, this clinical trial is still open for enrolment. The study was first published on the 17th of June 2019 and the data has been updated most recently in September 2022."
What is the cap on participant capacity in this clinical trial?
"Affirmative. The information on clinicaltrials.gov suggests that this research project is actively enrolling individuals. It was first introduced to the public on June 17th 2019 and its most recent update took place on September 21st 2022. A total of 206 patients will be sought out from 1 site for participation in this trial."
Share this study with friends
Copy Link
Messenger